These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 29896679)
1. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer. Fukayama M; Kunita A; Kaneda A Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations. Abe H; Kaneda A; Fukayama M Pathobiology; 2015; 82(5):212-23. PubMed ID: 26337667 [TBL] [Abstract][Full Text] [Related]
3. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer. Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548 [TBL] [Abstract][Full Text] [Related]
4. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage. Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459 [TBL] [Abstract][Full Text] [Related]
5. Update on Epstein-Barr virus and gastric cancer (review). Shinozaki-Ushiku A; Kunita A; Fukayama M Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Yang J; Liu Z; Zeng B; Hu G; Gan R Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463 [TBL] [Abstract][Full Text] [Related]
7. Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer. Kang BW; Baek DW; Kang H; Baek JH; Kim JG Anticancer Res; 2019 Aug; 39(8):4003-4010. PubMed ID: 31366481 [TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma. Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374 [TBL] [Abstract][Full Text] [Related]
9. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis. Morales-Sanchez A; Fuentes-Panana EM Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953 [TBL] [Abstract][Full Text] [Related]
11. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation. Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454 [TBL] [Abstract][Full Text] [Related]
13. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population. Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949 [TBL] [Abstract][Full Text] [Related]
14. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522 [TBL] [Abstract][Full Text] [Related]
15. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma. Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. Chen JN; He D; Tang F; Shao CK J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576 [TBL] [Abstract][Full Text] [Related]
18. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma. Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer. Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer. Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]